1. Mummaneni PV, Dhall SS, Eck JC, et al. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine: part 11. Interbody techniques for lumbar fusion. J Neurosurg Spine 2014;21:67–74.
2. Fujibayashi S, Hynes RA, Otsuki B, Kimura H, Takemoto M, Matsuda S. Effect of indirect neural decompression through oblique lateral interbody fusion for degenerative lumbar disease. Spine (Phila Pa 1976) 2015;40:E175–82.
3. Mobbs RJ, Phan K, Malham G, Seex K, Rao PJ. Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP, LLIF and ALIF. J Spine Surg 2015;1:2–18.
4. Schwender JD, Holly LT, Rouben DP, Foley KT. Minimally invasive transforaminal lumbar interbody fusion (TLIF): technical feasibility and initial results. J Spinal Disord Tech 2005;18(Suppl): S1–6.
6. Lau D, Khan A, Terman SW, Yee T, La Marca F, Park P. Comparison of perioperative outcomes following open versus minimally invasive transforaminal lumbar interbody fusion in obese patients. Neurosurg Focus 2013;35:E10.
7. Singhatanadgige W, Promsuwan M, Tanasansomboon T, Yingsakmongkol W, Limthongkul W. Is unilateral minimally invasive transforaminal lumbar interbody fusion sufficient in patients with claudication?: a comparative matched cohort study. World Neurosurg 2021;150:e735–40.
9. Sembrano JN, Tohmeh A, Isaacs R. SOLAS Degenerative Study Group. Two-year comparative outcomes of mis lateral and mis transforaminal interbody fusion in the treatment of degenerative spondylolisthesis: part I. Clinical findings. Spine (Phila Pa 1976) 2016;41(Suppl 8): S123–32.
10. Isaacs RE, Sembrano JN, Tohmeh AG. SOLAS Degenerative Study Group. Two-year comparative outcomes of mis lateral and mis transforaminal interbody fusion in the treatment of degenerative spondylolisthesis: part II. Radiographic findings. Spine (Phila Pa 1976) 2016;41(Suppl 8): S133–44.
11. Lin GX, Akbary K, Kotheeranurak V, et al. Clinical and radiologic outcomes of direct versus indirect decompression with lumbar interbody fusion: a matched-pair comparison analysis. World Neurosurg 2018;119:e898–909.
12. Limthongkul W, Tanasansomboon T, Yingsakmongkol W, Tanaviriyachai T, Radcliff K, Singhatanadgige W. Indirect decompression effect to central canal and ligamentum flavum after extreme lateral lumbar interbody fusion and oblique lumbar interbody fusion. Spine (Phila Pa 1976) 2020;45:E1077–84.
13. Miscusi M, Ramieri A, Forcato S, et al. Comparison of pure lateral and oblique lateral inter-body fusion for treatment of lumbar degenerative disk disease: a multicentric cohort study. Eur Spine J 2018;27(Suppl 2): 222–8.
16. Singhatanadgige W, Sukthuayat A, Tanaviriyachai T, et al. Risk factors for polyetheretherketone cage subsidence following minimally invasive transforaminal lumbar interbody fusion. Acta Neurochir (Wien) 2021;163:2557–65.
17. Seng C, Siddiqui MA, Wong KP, et al. Five-year outcomes of minimally invasive versus open transforaminal lumbar interbody fusion: a matched-pair comparison study. Spine (Phila Pa 1976) 2013;38:2049–55.
19. Ge DH, Stekas ND, Varlotta CG, et al. Comparative analysis of two transforaminal lumbar interbody fusion techniques: open TLIF versus Wiltse MIS TLIF. Spine (Phila Pa 1976) 2019;44:E555–60.
21. Sato J, Ohtori S, Orita S, et al. Radiographic evaluation of indirect decompression of mini-open anterior retroperitoneal lumbar interbody fusion: oblique lateral interbody fusion for degenerated lumbar spondylolisthesis. Eur Spine J 2017;26:671–8.
22. Khajavi K, Shen A, Hutchison A. Substantial clinical benefit of minimally invasive lateral interbody fusion for degenerative spondylolisthesis. Eur Spine J 2015;24(Suppl 3): 314–21.